LARGE / MID-CAP BIOPHARMA

IPSEN (IPN)

Paris, France · Europe
ONCOLOGY
RARE DISEASES
NEUROSCIENCE
LARGE / MID-CAP BIOPHARMA
HEADQUARTERS
Paris, France
TICKER
IPN
SEGMENT
Large / Mid-cap Biopharma
THERAPY AREAS
Oncology, rare diseases, neuroscience
KEY PRODUCTS
PRODUCTDETAILS
Cabometyx (ex-US)
Somatuline
Dysport
COMPANY OVERVIEW

Specialty biopharma with oncology and rare disease portfolio and a consumer aesthetics product line.

IPSEN — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →